BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23343966)

  • 1. Comparison of the clinicopathological characteristics and results of endoscopic submucosal dissection for esophagogastric junction and non-junctional cancers.
    Hoteya S; Matsui A; Iizuka T; Kikuchi D; Yamada A; Yamashita S; Furuhata T; Domon K; Nakamura M; Mitani T; Ogawa O; Kasie M
    Digestion; 2013; 87(1):29-33. PubMed ID: 23343966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical impact of endoscopic submucosal dissection for superficial adenocarcinoma located at the esophagogastric junction.
    Yoshinaga S; Gotoda T; Kusano C; Oda I; Nakamura K; Takayanagi R
    Gastrointest Endosc; 2008 Feb; 67(2):202-9. PubMed ID: 18226681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic submucosal dissection plus radiofrequency ablation of neoplastic Barrett's esophagus.
    Neuhaus H; Terheggen G; Rutz EM; Vieth M; Schumacher B
    Endoscopy; 2012 Dec; 44(12):1105-13. PubMed ID: 22968641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcome in patients treated with endoscopic submucosal dissection for superficial Barrett's neoplasia.
    Chevaux JB; Piessevaux H; Jouret-Mourin A; Yeung R; Danse E; Deprez PH
    Endoscopy; 2015 Feb; 47(2):103-12. PubMed ID: 25412090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic resection (endoscopic submucosal dissection/endoscopic mucosal resection) for superficial Barrett's esophageal cancer.
    Koike T; Nakagawa K; Iijima K; Shimosegawa T
    Dig Endosc; 2013 Mar; 25 Suppl 1():20-8. PubMed ID: 23480400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological features of Siewert type II adenocarcinoma: comparison of gastric cardia adenocarcinoma and Barrett's esophageal adenocarcinoma following endoscopic submucosal dissection.
    Osumi H; Fujisaki J; Omae M; Shimizu T; Yoshio T; Ishiyama A; Hirasawa T; Tsuchida T; Yamamoto Y; Kawachi H; Yamamoto N; Igarashi M
    Gastric Cancer; 2017 Jul; 20(4):663-670. PubMed ID: 27783167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superficial adenocarcinoma of the esophagogastric junction: long-term results of endoscopic submucosal dissection.
    Hirasawa K; Kokawa A; Oka H; Yahara S; Sasaki T; Nozawa A; Tanaka K
    Gastrointest Endosc; 2010 Nov; 72(5):960-6. PubMed ID: 21034897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoscopic Submucosal Dissection for Adenocarcinomas of the Esophagogastric Junction.
    Nagami Y; Ominami M; Otani K; Hosomi S; Tanaka F; Taira K; Kamata N; Yamagami H; Tanigawa T; Shiba M; Watanabe T; Fujiwara Y
    Digestion; 2018; 97(1):38-44. PubMed ID: 29393168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early esophageal cancer in Europe: endoscopic treatment by endoscopic submucosal dissection.
    Probst A; Aust D; Märkl B; Anthuber M; Messmann H
    Endoscopy; 2015 Feb; 47(2):113-21. PubMed ID: 25479563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment Outcomes of Endoscopic Submucosal Dissection for Adenocarcinoma Originating from Long-Segment Barrett's Esophagus versus Short-Segment Barrett's Esophagus.
    Shimizu T; Fujisaki J; Omae M; Yamasaki A; Horiuchi Y; Ishiyama A; Yoshio T; Hirasawa T; Yamamoto Y; Tsuchida T
    Digestion; 2018; 97(4):316-323. PubMed ID: 29539629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of endoscopic submucosal dissection for tumors of the esophagogastric junction.
    Kakushima N; Yahagi N; Fujishiro M; Kodashima S; Nakamura M; Omata M
    Endoscopy; 2006 Feb; 38(2):170-4. PubMed ID: 16479425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Endoscopic therapy for cancer of the esophagogastric junction].
    Fujisaki J; Omae M; Shimizu T; Morishige K; Miyamoto Y; Taniguchi C; Horiuchi Y; Yoshio T; Ishiyama A; Hirasawa T; Yamamoto Y; Tsuchida T; Igarashi M
    Nihon Geka Gakkai Zasshi; 2015 Jan; 116(1):29-34. PubMed ID: 25842810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Limited surgical resection versus local endoscopic therapy of early cancers of the esophagogastric junction].
    von Rahden BH; Feith M; Stein HJ
    Zentralbl Chir; 2006 Apr; 131(2):97-104. PubMed ID: 16612774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes of superficial neoplasia at the esophagogastric junction treated via endoscopic submucosal dissection and endoscopic submucosal tunnel dissection: a cohort study of a single center from China.
    Liu S; Chai N; Lu Z; Li H; Xiong Y; Zhai Y; Linghu E
    Surg Endosc; 2020 Jan; 34(1):216-225. PubMed ID: 30993514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic mucosal resection for staging and therapy of adenocarcinoma of the esophagus, gastric cardia, and upper gastric third.
    Heinrich H; Bauerfeind P
    Recent Results Cancer Res; 2010; 182():85-91. PubMed ID: 20676873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes of endoscopic submucosal dissection for early stage esophagogastric junction cancer: a systematic review and meta-analysis.
    Park CH; Kim EH; Kim HY; Roh YH; Lee YC
    Dig Liver Dis; 2015 Jan; 47(1):37-44. PubMed ID: 25454708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and curative ability of endoscopic submucosal dissection for superficial esophageal cancers at least 50 mm in diameter.
    Yamashina T; Ishihara R; Uedo N; Nagai K; Matsui F; Kawada N; Oota T; Kanzaki H; Hanafusa M; Yamamoto S; Hanaoka N; Takeuchi Y; Higashino K; Iishi H
    Dig Endosc; 2012 Jul; 24(4):220-5. PubMed ID: 22725105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Submucosal tumors of the esophagogastric junction originating from the muscularis propria layer: a large study of endoscopic submucosal dissection (with video).
    Li QL; Yao LQ; Zhou PH; Xu MD; Chen SY; Zhong YS; Zhang YQ; Chen WF; Ma LL; Qin WZ
    Gastrointest Endosc; 2012 Jun; 75(6):1153-8. PubMed ID: 22459663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of endoscopic submucosal dissection for early gastric cancer with special reference to validation for curability criteria.
    Goto O; Fujishiro M; Kodashima S; Ono S; Omata M
    Endoscopy; 2009 Feb; 41(2):118-22. PubMed ID: 19214889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasion of poorly differentiated adenocarcinoma to the deep muscularis mucosae may be an indicator of lymph node metastasis in Barrett's esophageal cancer.
    Sakaguchi Y; Ono S; Fujishiro M; Yamamichi N; Koike K
    Dig Endosc; 2013 May; 25 Suppl 2():168-72. PubMed ID: 23617671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.